James Mallinson
Portfolio Director for Spinout Equity Management @ Oxford University Innovation
Oxford, United Kingdom
James Mallinson is a Series A investor at Oxford University Innovation in Oxford focused on Health Care and Biotechnology. James Mallinson
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries James Mallinson invests in
Stages James Mallinson invests in
Countries James Mallinson invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Manufacturing 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Orbit Discovery is a peptide display company identifying potential peptide drugs for a range of chronic diseases. Peptides offer the potential to make drugs with the specificity and efficacy of large biologic molecules combined with the smaller dose size, simpler routes of delivery and lower cost of manufacturing found with small molecules. Theyare, therefore, uniquely suited to the treatment of chronic diseases which impact large patient populations. Their technology supports all of the improvements that can be made to peptides which make them better drugs whilst simplifying the discovery process and accelerating drug development | $9.2M / Series A / May 23, 2018 |
Co-Investors
Oxford University Innovation is the University of Oxford's technology transfer company and manages the University's intellectual property portfolio, working with University researchers on identifying, protecting and marketing technologies through licensing, spin-out company formation and material sales. Oxford University Innovation alsomanages Oxford University Consulting, which arranges consulting services providing clients access to the expertise of the University's academics.Oxford University’s overarching Strategic Plan begins, “The University of Oxford aims to lead the world in research and education” immediately followed by, “They seek to do this in ways which benefit society on a national and a global scale.”Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Their role is to help University staff and students bring the benefits of their research and expertise to create impact in wider society. They support Oxford’s researchers, staff and students, offering commercial skills and a range of specialist resources in order to maximise research impact. Income is shared with those involved according to the University’s Regulations.
Oxford University Innovation Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Adam Stoten
Chief Operating Officer
|
|||
Gregg Bayes-Brown
Marketing and Communications Manager
|
|||
Mairi Gibbs
Head of Operations
|
|||
Philip Jordan
Principal - Licensing and Ventures
|
|||
Ajoy Mallik
Oxford Angels Network
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does James Mallinson invest in?
James Mallinson invests primarily in Health Care, Biotechnology and Manufacturing startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact James Mallinson?
Public channels for James Mallinson include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did James Mallinson last invest?
The most recent investment recorded for James Mallinson closed in May 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
